Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
21 August 2025 | Story Tshepo Tsotetsi | Photo Tshepo Tsotetsi
EMS Womens Function
From the left: Prof Brownhilder Neneh, Vice-Dean of the Faculty of Economic and Management Sciences; Prof Hester C. Klopper, Vice-Chancellor and Principal of the UFS; Simone Williams, Faculty Manager; and Dr Celeste Campher, Senior Lecturer in the Faculty of Economic and Management Sciences, at the Women’s Function held on the Bloemfontein Campus on 18 August.

The University of the Free State’s (UFS) Faculty of Economic and Management Sciences recently hosted a Women’s Function on the UFS Bloemfontein Campus – an event that paid tribute to women’s leadership in academia during Women’s Month. The gathering, held on 18 August 2025, was marked by a historic conversation with Prof Hester C. Klopper, UFS Vice-Chancellor and Principal, who earlier this year became the first woman to lead the university in its 121-year history.

The function brought together women academics and professional staff in an atmosphere of connection and reflection to converse on breaking barriers, building futures, and empowering women in higher education. In conversation with colleagues, Prof Klopper shared her personal journey in higher education, her leadership philosophy, and the values that have guided her career. The occasion created a meaningful platform for colleagues to reflect on the role of women in shaping the future of the faculty and the university.

 

Breaking barriers, building futures

Prof Klopper described her appointment as both humbling and historic: “It is an extraordinary honour to be entrusted with this responsibility. This milestone is not just a personal achievement, but also a reflection of the progress we have made as a university and as a society in recognising and valuing diversity in leadership. I stand on the shoulders of many trailblazers who paved the way, and I hope my appointment inspires women to believe that there are no limits to what they can achieve.”

She shared pivotal moments across her career journey – from transitioning into academia to international leadership experiences that shaped her vision. “You become aware of a growing, burning desire to plough back what you have learned; to pay forward in some way after receiving so many opportunities for growth, so much exposure to great role models, and such incredible learning experiences,” she said.

Acknowledging the challenges women still face in higher education, Prof Klopper reflected: “Academia has traditionally been male-dominated. In order to overcome stereotyping and bias, I drew on the values instilled by my parents – hard work, believing in yourself, non-discrimination, fairness, and care. These have been incredibly valuable in my journey.” She also highlighted the importance of supportive partnerships when balancing professional and family responsibilities.

Prof Brownhilder Neneh, Vice-Dean: Research, Engagement and Internationalisation in the Faculty, said these reflections captured the very purpose of the gathering. “With Prof Klopper serving as the first female Vice-Chancellor and Principal of the UFS, it was important to create a platform for her to inspire and empower women academics,” she said. “By sharing her career journey and insights, she demonstrated how barriers can be overcome in higher education leadership.” 

She added that the conversation reinforced an important message: “Women, too, can achieve whatever they aspire to become. Prof Klopper reminded us that one must be clear about the message they want to communicate, know what they stand for, and remain consistent, authentic and honest. She emphasised the importance of always considering what you bring to the table – your expertise and knowledge – which ultimately opens doors. She also reminded us that women need to create their own values and live them, be intentional, and show up. There is no single recipe – each person must find their own rhythm and pursue it deliberately.”

Prof Klopper echoed with a message of encouragement to young women: “Have the courage to embrace your own authentic leadership style. Do not allow others to define who you are – believe in your own abilities. Knowledge without action is incomplete. Lead with heart, take intellectual risks, and remember that talent exists everywhere, but you have the power to create opportunity.”

Prof Neneh added that the event was not only a celebration but also a call to action: “Women play a vital role in enriching the academic project by bringing diverse experiences, perspectives, and leadership approaches. I hope colleagues left encouraged to pursue their aspirations with confidence and inspired to embrace mentorship, sponsorship, and solidarity among women academics.”

News Archive

Research contributes to improving quality of life for cancer patients
2016-11-21

Description: Inorganic Chemistry supervisors  Tags: Inorganic Chemistry supervisors

Inorganic Chemistry supervisors in the Radiopharmacy
Laboratory during the preparation of a typical complex
mixture to see how fast it reacts. Here are, from the left,
front: Dr Marietjie Schutte-Smith, Dr Alice Brink
(both scholars from the UFS Prestige
Scholar Programme), and Dr Truidie Venter (all three
are Thuthuka-funded researchers).
Back: Prof André Roodt and Dr Johan Venter.
Photo: Supplied

Imagine that you have been diagnosed with bone cancer and only have six months to live. You are in a wheelchair because the pain in your legs is so immense that you can’t walk anymore – similar to a mechanism eating your bones from the inside.

You are lucky though, since you could be injected with a drug to control the pain so effective that you will be able to get out of the wheelchair within a day-and-a-half and be able to walk again. Real-life incidents like these provide intense job satisfaction to Prof André Roodt, Head of Inorganic Chemistry at the University of the Free State (UFS). The research, which is conducted by the Inorganic Group at the UFS, contributes greatly to the availability of pain therapy that does not involve drugs, but improves the quality of life for cancer patients.

The research conducted by the Inorganic Group under the leadership of Prof Roodt, plays a major role in the clever design of model medicines to better detect and treat cancer.

The Department of Chemistry is one of approximately 10 institutions worldwide that conducts research on chemical mechanisms to identify and control cancer. “The fact that we are able to cooperate with the Departments of Nuclear Medicine and Medical Physics at the UFS, the Animal Research Centre, and other collaborators in South Africa and abroad, but especially the methodology we utilise to conduct research (studying the chemical manner in which drugs are absorbed in cancer as well as the time involved), enhances the possibility of making a contribution to cancer research,” says Prof Roodt.

Technique to detect cancer spots on bone
According to the professor, there are various ways of detecting cancer in the body. Cancer can, inter alia, be identified by analysing blood, X-rays (external) or through an internal technique where the patient is injected with a radioactive isotope.

Prof Roodt explains: “The doctor suspects that the patient has bone cancer and injects the person with a drug consisting of an isotope (only emits X-rays and does no damage to tissue) that is connected to a phosphonate (similar to those used for osteoporosis). Once the drug is injected, the isotope (Technetium-99m) moves to the spot on the bone where the cancer is located. The gamma rays in the isotope illuminate the area and the doctor can see exactly where treatment should be applied. The Technetium-99m has the same intensity gamma rays as normal X-rays and therefore operates the same as an internal X-ray supply.” With this technique, the doctor can see where the cancer spots are within a few hours.

The same technique can be used to identify inactive parts of the brain in Alzheimer patients, as well as areas of the heart where there is no blood supply or where the heart muscle is dead.

Therapeutic irradiation of cancer
For the treatment of pain connected with cancer, the isotope Rhenium-186 is injected. Similar to the manner in which the Technetium-99m phosphonate compound is ingested into the body, the Rhenium-186 phosphonate travels to the cancer spots. Patients thus receive therapeutic irradiation – a technique known as palliative therapy, which is excellent for treating pain. A dosage of this therapy usually lasts for about two months.

The therapy is, however, patient specific. The dosages should correspond with the occurrence and size of cancer spots in the patient’s body. First, the location of the cancer will be determined by means of a technetium scan. After that, the size of the area where the cancer occurs has to be determined. The dosage for addressing total pain distribution will be calculated according to these results.

Technique to detect cancer spots on soft tissue
Another technique to detect cancer as spots on bone or in soft tissue and organs throughout the body is by utilising a different type of irradiation, a so-called PET isotope. The Fluor-18 isotope is currently used widely, and in Pretoria a machine called a cyclotron was produced by Dr Gerdus Kemp, who is a former PhD graduate from the Inorganic Research Group. The F-18 is then hidden within a glucose molecule and a patient will be injected with the drug after being tranquillised and after the metabolism has been lowered considerably. The glucose, which is the ‘food' that cancer needs to grow, will then travel directly to the cancer area and the specific area where the cancer is located will thus be traced and ‘illuminated’ by the Fluor-18, which emits its own 'X-rays'.

In the late 80s, Prof Roodt did his own postdoctoral study on this research in the US. He started collaborating with the Department of Nuclear Medicine at the UFS in the early 90s, when he initiated testing for this research.

Through their research of more than 15 years, the Inorganic Group in the Department of Chemistry has made a major contribution to cancer research. Research on mechanisms for the detection of cancer, by designing new clever chemical agents, and the chemical ways in which these agents are taken up in the body, especially contributes to the development in terms of cancer therapy and imaging, and has been used by a number of hospitals in South Africa.

The future holds great promise
Prof Roodt and his team are already working on a bilateral study between the UFS and Kenya. It involves the linking of radio isotopes, as mentioned above, to known natural products (such as rooibos tea), which possess anti-cancer qualities.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept